A Simple RP-HPLC Method to Simultaneously Assay the Contents of Lamivudine, Tenofovir, and Nevirapine in Fixed Dose Combined Oral Antiviral Medicines

Table 4

Percentage content obtained for sampled products.

	Analyte	Content (%)	Acceptance criteria (%)	Inference
Sample A	TDF	97.50 ± 0.75		Passed
	3TC	97.72 ± 0.09		Passed
Sample B1	TDF	98.55 ± 0.17	90–110	Passed
	3TC	105.33 ± 0.85		Passed
Sample B2	NVP	99.20 ± 1.17		Passed